Print

ANRS VAC 02

Trial Details:

I Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS) Aventis-Pasteur July 01, 1992
rgp 160 + peptide V3 ANRS VAC 02 Env gp160 (gp120 MN, gp41 LAI); V3 MN
rgp 160 + peptide V3 ANRS VAC 02 Protein
France 25
http://www.anrs.fr/